HbA1c target achievement in the elderly: results of the Titration and Optimization trial for initiation of insulin glargine 100 U/mL in patients with type 2 diabetes poorly controlled on oral antidiabetic drugs

Eitemau Tebyg

• Effectiveness and safety of insulin glargine 300 U/mL in insulin‐naïve patients with type 2 diabetes after failure of oral therapy in a real‐world setting
  gan: Pfohl, Martin, et al.
  Cyhoeddwyd: (2020)
• Effectiveness and tolerability of treatment intensification to basal–bolus therapy in patients with type 2 diabetes on previous basal insulin-supported oral therapy with insulin glargine or supplementary insulin therapy with insulin glulisine: the PARTNER observational study
  gan: Pfohl, Martin, et al.
  Cyhoeddwyd: (2015)
• Efficacy and safety of insulin glargine added to a fixed-dose combination of metformin and a dipeptidyl peptidase-4 inhibitor: results of the GOLD observational study
  gan: Seufert, Jochen, et al.
  Cyhoeddwyd: (2013)
• The relationship between HbA1c and hypoglycaemia in patients with diabetes treated with insulin degludec versus insulin glargine 100 units/mL
  gan: Philis‐Tsimikas, Athena, et al.
  Cyhoeddwyd: (2020)
• Similar glycaemic control and less hypoglycaemia during active titration after insulin initiation with glargine 300 units/mL and degludec 100 units/mL: A subanalysis of the BRIGHT study
  gan: Cheng, Alice, et al.
  Cyhoeddwyd: (2019)